Arcellx, Inc. (ACLX)
Apr 28, 2026 - ACLX was delisted (reason: acquired by GILD)
115.07
0.00 (0.00%)
Inactive · Last trade price on Apr 27, 2026
Arcellx Employees
Arcellx had 209 employees as of December 31, 2025. The number of employees increased by 46 or 28.22% compared to the previous year.
Employees
209
Change (1Y)
46
Growth (1Y)
28.22%
Revenue / Employee
$106,632
Profits / Employee
-$1,095,378
Market Cap
6.75B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 209 | 46 | 28.22% |
| Dec 31, 2024 | 163 | 33 | 25.38% |
| Dec 31, 2023 | 130 | 32 | 32.65% |
| Dec 31, 2022 | 98 | 20 | 25.64% |
| Dec 31, 2021 | 78 | 47 | 151.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
ACLX News
- 13 days ago - Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel - Business Wire
- 7 weeks ago - Halper Sadeh LLC is Investigating Whether KW, ACLX are Obtaining Fair Deals for their Shareholders - GlobeNewsWire
- 2 months ago - Here's Why Shares of Arcellx Are Up Almost 80% Today - Investopedia
- 2 months ago - Why is Arcellx stock up 80% today? Gilead's $7.8B answer - Invezz
- 2 months ago - Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion - Reuters
- 2 months ago - Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion - WSJ
- 2 months ago - Gilead to acquire Arcellx for $7.8 billion - Reuters
- 2 months ago - Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel - Business Wire